Tabernanthe iboga

Botany

Morphology and life history

An evergreen, much-branched shrub commonly about 1–3 m tall, occasionally developing into a small tree approaching 10 m. Opposite leaves are simple, narrow-elliptic to lanceolate, glossy dark green above and paler beneath. Like many Apocynaceae it exudes milky latex when injured. Small, fragrant, tubular flowers are white to yellowish or pink-tinged and borne in compact axillary clusters. The paired fruits mature yellow to orange and range from subglobose to elongate or fusiform; their fleshy pulp encloses numerous seeds. A thick yellowish root system supports the plant, while the outer root tissues are the principal harvested alkaloid source (Schultes and Hofmann, 1980; Pope, 1969).

The concentration of valued alkaloids in root cortex creates a conservation problem unlike leaf harvest: stripping or uprooting may debilitate or kill a slow-establishing shrub. Cultivated plants can be raised from seed and propagated vegetatively, but seed viability, provenance and years to substantial root formation affect restoration and supply. Cultivation is therefore both biological management and a social question about who controls land, germplasm, labour and ceremonial access (Ermakova et al., 2025; ICEERS, 2026).

Identification and taxonomic limits

Chemistry

Iboga contains a structurally elaborate ensemble of monoterpene indole alkaloids. Ibogaine is usually the most discussed constituent of root bark, but whole-root preparations also contain ibogamine, tabernanthine, ibogaline, iboxygaine, voacangine, coronaridine and further minor alkaloids. Abundance depends on tissue, plant, provenance, storage and method. Noribogaine is most important pharmacologically as the active human metabolite formed largely through CYP2D6, not as a synonym for the plant’s native alkaloid profile (Bading-Taika et al., 2018; Iyer et al., 2021).

Distribution, biosynthesis and metabolism

One characterised powder contained 1.93% ibogaine by dry weight, with ibogaine contributing about one quarter of detected chromatographic alkaloid signal; that figure is a specimen result, not a species constant (Bading-Taika et al., 2018). Analysis of retail materials reported root-bark products ranging roughly 0.6–11.2% ibogaine, demonstrating why labels, colour and declared mass cannot establish composition (Bouso et al., 2020). Enzymatic studies identified coronaridine hydroxylation and methylation steps in the plant’s route to ibogaine and later reconstructed the pathway to voacangine, opening non-extractive routes to related alkaloids (Farrow et al., 2018; 2019).

In humans, ibogaine is lipophilic and is O-demethylated principally by CYP2D6 to noribogaine. Genetic metaboliser status, liver function and interacting medicines can change exposure. Ibogaine and noribogaine have different time courses and target profiles; noribogaine persists longer and has prominent serotonin-transporter and opioid-receptor activity. Neither compound is well represented by the shorthand “a 5-HT₂A psychedelic” (Glue et al., 2016; Knuijver et al., 2024).

Neuropharmacology and toxicology

Tradition, ritual & cultural use

Oldest evidenced or proposed human use

Peoples, territories and traditions

Ritual practice, shamanism and healing

The relevant specialists are variously nganga, lineage elders, harpists, singers, dancers, attendants and office-holders; translating every role as “shaman” erases this division of ritual labour. Initiation makes a banzi/banzie through collective supervision rather than private intoxication. Preparation can include seclusion, fasting, bathing, confession, bodily marking and instruction. During the central night or sequence of nights, the initiate commonly reclines near the ceremonial action while attendants monitor bodily condition, sustain music and ask what is being seen. The event culminates in public recognition, teaching and return to ordinary social relations (Fernandez, 1972; 1982).

Fernandez described the ritual aim as a return to “the path of life and death” and “the work of the ancestors” (Fernandez and Fernandez, 2001, pp. 235–269). These compact phrases locate healing in genealogy and obligation: the initiate does not simply acquire an extraordinary private state but is re-situated between the dead and unborn, village and forest, personal biography and collective history.

Cosmology & key terms

Plural origin narratives

There is no single canonical iboga myth. In a widely reported Mitsogo narrative cycle, a woman—named or associated with Disumba in some tellings—first consumes iboga, crosses into the world of the dead and is subsequently killed or sacrificed. Her remains become ritual instruments or founding substances; her voice becomes the ngombi harp. A male culture hero returns with knowledge, relics or the means to build the first temple. Versions redistribute agency, gender and guilt, and later Fang tellings may identify figures through Christian names or biblical history (Fernandez, 1982; Samorini, 2024b).

The plant’s downward-growing root readily participates in a vertical cosmology of earth and ancestors, while the all-night ceremony moves through darkness toward dawn. Yet “underworld,” “death” and “rebirth” are analytical translations of locally elaborated places, persons and routes. Bweté cosmology is also historical: ancestors legitimise fertility and descent, Christian symbols can articulate colonial encounter, and national or urban predicaments enter sermon, song and vision (Fernandez, 1982; Mary, 1983).

Art, sound and ceremonial space

Music as visionary technique

Music supplies pulse, direction, memory and interpersonal control across a state that can last far longer than the most image-rich phase. Repeated ostinati, accelerating dance, antiphonal singing and instrumental timbres can be heard as voices, vehicles or presences. The ensemble also keeps the surrounding community awake and able to witness the initiate. Phenomenology is therefore jointly produced by alkaloids, darkness, fatigue, sound, expectation, bodily position and questioning; the chemistry is necessary to describe the drug state but insufficient to describe the ritual world (Fernandez, 1972; Maas and Strubelt, 2003).

Visionary phenomenology

Durations are approximate syntheses from ibogaine studies and ethnographic descriptions, not a timetable for root bark. Plant composition, metabolism, co-administered substances, fasting and ceremonial pacing all alter the course. Traditional initiations may surround the acute pharmacology with two or more days of preparation, night work and recovery (Fernandez, 1982; Kohek et al., 2020).

Recurrent experiential sequence

Accounts and interpretation

Kohek and colleagues’ interviews with twenty ibogaine users identified physical, sensory, visual, auditory, cognitive, adverse and after-effect domains, including ancestors and entities, landscapes, horrific scenes, self-analysis, empathy, catharsis, ego dissolution and spiritual states (Kohek et al., 2020). A separate qualitative study of underground treatment emphasised autobiographical memory, interpersonal and transpersonal experience, preparation, integration and motivation for lifestyle change (Rodríguez-Cano et al., 2023). These samples are self-selected and do not establish frequency in all users.

> It was like watching my life as a film, but I could stop and speak to the people in it. — — paraphrased composite of recurrent interview descriptions; Kohek et al. (2020), not a verbatim single-participant quotation

The composite is labelled because striking internet quotations often lose provenance. Ethnographically, an image of a dead relative may be recognised as ancestral communication; psychologically, it may be coded as autobiographical memory or grief processing; neurologically, it remains a subjective report correlated with a drug state. The descriptions can coexist as different explanatory registers without being collapsed into one another.

In 2026, analysis of post-session narratives from thirty male Special Operations veterans reported four recurring domains: dialogic trauma reappraisal and guided replay; altered self and mystical connectedness; emotional resolution through forgiveness, love and purpose; and embodied healing or clarity (Olash et al., 2026). The cohort had received magnesium–ibogaine with complementary care in Mexico. Its language cannot be treated as Bwiti phenomenology or as controlled evidence that a particular vision caused clinical change.

Contemporary status

Conservation, harvest and economies

T. iboga is globally assessed as Least Concern, reflecting its broad range rather than abundance at every harvest site (BGCI and IUCN SSC Global Tree Specialist Group, 2019). Forest loss, destructive root harvest and international demand can nevertheless produce local scarcity. Gabonese ceremonial markets, village cultivation, cross-border wild harvest, internet retail, retreat tourism and pharmaceutical research form overlapping economies with very unequal prices and authority (Ermakova et al., 2025; INTERPOL, 2023).

Law, access and benefit-sharing

Patents and translation

Howard Lotsof’s 1985 US patent 4,499,096 claimed a method of interrupting narcotic addiction with ibogaine; later patents extended claims across cocaine, alcohol, nicotine and polysubstance dependence (Lotsof, 1985). Contemporary portfolios concern noribogaine, purified formulations, salts, analogues, methods of treatment and potentially less cardiotoxic congeners. A patent grants limited claims in a jurisdiction; it does not establish safety, approval, ownership of T. iboga as a species or ownership of Bwiti knowledge. The policy issue is how invention, prior art, genetic-resource access and benefits to source communities are documented (Bonhomme, 2023).

Clinical and neuroscience research

Open-label and observational studies in opioid-dependent participants report rapid reduction of withdrawal and craving and, in some cohorts, reduced subsequent use. They also contain selection bias, variable psychosocial care and limited controls; one New Zealand cohort included a death during treatment (Brown and Alper, 2018; Noller, Frampton and Yazar-Klosinski, 2018; Mash et al., 2018). A monitored open-label safety study documented frequent QTc prolongation and clinically important bradycardia, reinforcing rather than resolving cardiac risk (Knuijver et al., 2022). The registered Phase I/IIa opioid-withdrawal study NCT05029401 has not had its status verified within two years and is treated by ClinicalTrials.gov as unknown/closed (ClinicalTrials.gov, 2026).

The research frontier is active but asymmetrical: sophisticated chemistry and human neuroimaging now coexist with sparse population ecology, limited pharmacognosy of ceremonial material and relatively little funded scholarship led by Gabonese practitioners and scientists. A species monograph must keep these evidentiary scales visible.

Bibliography

Cross-correlations